ESC 365 - Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk . A Meta-analysis.

ESC Premium Access

Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk . A Meta-analysis.

Session: HDL cholesterol - A moving target

Topic: Drug therapy

Speaker: Doctor L. Lobo (Buenos Aires, AR)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Lorenzo Martin Lobo

Campo de Mayo Military Hospital, Buenos Aires (Argentina)

0 follower

4 more presentations in this session

Mechanistic insights into HDL cholesterol - Current insights.

Speaker: Professor A. Tybjaerg-Hansen (Copenhagen, DK)

Elevated HDL-C is associated with adverse cardiovascular outcomes

Speaker: Doctor M. Allard-Ratick (Atlanta, US)

Serum modified high density lipoprotein levels assessed by a novel assay was associated with coronary artery calcification in an apparently healthy population

Speaker: Professor T. Okamura (Tokyo, JP)

Next steps in addressing HDL cholesterol clinical practice.

Speaker: Professor A. Catapano (Milan, IT)

Access the full session

HDL cholesterol - A moving target

Speakers: Doctor L. Lobo, Professor A. Tybjaerg-Hansen, Doctor M. Allard-Ratick, Professor T. Okamura, Professor A. Catapano

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources